GO:0098992 neuronal dense core vesicle: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098992 neuronal dense core vesicle describes a dense core granule located in neurons that typically stores neuropeptides and can be found in the soma, dendrites, axonal varicosities and synaptic terminals.
• Dense core vesicles (DCVs) are distinct from synaptic vesicles: they are larger, contain electron-dense cores, and undergo regulated release that depends on cytoskeletal capture and cAMP signaling.
• Key protein components include chromogranins (CHGA, CHGB), secretogranins, prohormone convertases, and the cytoskeletal/membrane machinery that mediates capture and fusion.
• DCV transport along axons requires kinesin-1, and defects in transport affect locomotion and lifespan in model organisms.
• DCV fusion capacity and pool replenishment can be measured quantitatively in hippocampal neurons, making them tractable for functional studies.
• Altered DCV markers have been reported in cerebrospinal fluid and cortical tissue from Alzheimer's disease patients, linking DCV biology to neurodegeneration.
Description
Neuronal dense core vesicles (DCVs) are specialized secretory organelles that store and release neuropeptides, growth factors and other signaling molecules. Unlike classical synaptic vesicles, DCVs are larger, contain an electron-dense core, and can be found throughout the neuron, including the soma, dendrites, axonal swellings (varicosities) and synaptic terminals. This broad distribution allows neurons to deliver neuromodulatory signals at multiple sites, shaping circuit activity and behavior. Because DCV cargoes include neuropeptides that regulate feeding, stress, pain and social behavior, understanding DCV biology is central to neurobiology and neuroendocrinology. At the cellular level, DCVs are formed at the trans-Golgi network, mature through the regulated secretory pathway, and are transported by microtubule motors to release sites. Their exocytosis is tightly controlled by cytoskeletal capture mechanisms and second-messenger signaling, particularly cAMP. Quantitative methods now allow researchers to measure DCV fusion capacity and pool replenishment in cultured neurons, providing a robust framework for mechanistic studies. This article summarizes the current understanding of GO:0098992 neuronal dense core vesicle, covering its definition, composition, molecular regulation, disease relevance and the experimental models used to study it. All statements are based on published literature cited by PMID.
neuronal dense core vesicle At A Glance
| GO ID | GO:0098992 |
|---|---|
| GO term | neuronal dense core vesicle |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Storage and regulated release of neuropeptides and other signaling molecules in neurons |
| Subcellular location | Soma, dendrites, axonal varicosities and synaptic terminals |
| Typical cargo | Neuropeptides, chromogranins, secretogranins and prohormone convertases |
| Transport machinery | Kinesin-1 mediates microtubule-dependent transport |
| Release regulation | Cytoskeletal capture and cAMP-dependent signaling |
What Is GO:0098992?
GO:0098992 neuronal dense core vesicle is defined as a dense core vesicle (granule) that is part of a neuron. These vesicles typically contain neuropeptides and can be found in all parts of neurons, including the soma, dendrites, axonal swellings (varicosities) and synaptic terminals. In practical terms, it is a membrane-bound organelle with an electron-dense core that serves as a storage and release compartment for neuropeptides and other signaling molecules in neurons.
Why Is neuronal dense core vesicle Important in Cell Biology?
Neuronal dense core vesicles are essential for neuromodulation and neuroendocrine signaling because they store and release neuropeptides that cannot be packaged into classical synaptic vesicles. Their ability to release cargo from multiple neuronal compartments allows for spatially and temporally diverse signaling, influencing processes such as synaptic plasticity, stress responses and behavior. Dysregulation of DCV biogenesis, transport or exocytosis has been linked to neurodegenerative conditions, including Alzheimer's disease, where DCV markers are altered in patient cerebrospinal fluid and cortical tissue. Thus, studying DCVs provides insight into fundamental neuronal communication and disease mechanisms.
• DCVs store neuropeptides that modulate neuronal excitability and circuit function.
• They are found in all neuronal compartments, enabling localized release.
• DCV exocytosis requires cAMP-dependent signaling and cytoskeletal capture.
• Kinesin-1-dependent transport is critical for DCV distribution and organismal physiology.
• Chromogranins A and B are major DCV cargo proteins affecting biogenesis and exocytosis.
• DCV fusion capacity and pool replenishment can be quantified in hippocampal neurons.
• Altered DCV markers are observed in Alzheimer's disease CSF and cortex.
• Tomosyn affects DCV composition without blocking exocytosis, revealing cargo sorting complexity.
• Synapsin is required for DCV capture and cAMP-dependent neuropeptide release.
• DCV research informs neuroendocrine disorders and potential therapeutic targets.
What Happens During neuronal dense core vesicle?
Biogenesis at the trans-Golgi network
In simple terms: DCVs are born at the Golgi apparatus, where cargo proteins are sorted into new vesicles.
Neuronal dense core vesicles originate from the trans-Golgi network, where prohormones and granins are packaged into nascent granules. Chromogranins A and B (CHGA, CHGB) are major constituents that contribute to the dense core structure and influence vesicle biogenesis. In neurons lacking chromogranins A and B, DCV biogenesis and exocytosis are altered, indicating their importance in granule formation.
Maturation and cargo processing
In simple terms: As DCVs mature, enzymes cut prohormones into active neuropeptides.
During maturation, prohormone convertases cleave precursor proteins into bioactive neuropeptides within the DCV lumen. Tomosyn affects DCV composition, suggesting a role in cargo sorting or retention, although it does not block exocytosis. This step ensures that the appropriate mix of signaling molecules is available for release.
Transport along microtubules
In simple terms: Motor proteins carry DCVs along the cytoskeleton to different parts of the neuron.
DCVs are transported by microtubule motors, with kinesin-1 playing a key role in their movement. In C. elegans, disruption of kinesin-1 affects DCV transport, locomotion and lifespan regulation, demonstrating the physiological importance of proper DCV trafficking. This transport allows DCVs to reach distant release sites such as axonal varicosities and synaptic terminals.
Capture and docking at release sites
In simple terms: DCVs are held in place at release sites by cytoskeletal proteins until a signal arrives.
Synapsin is required for DCV capture and cAMP-dependent neuropeptide release. This capture mechanism ensures that DCVs are available for sustained release and can replenish the releasable pool. The presynaptic cytomatrix provides structural organization for DCV docking and fusion.
Calcium-triggered exocytosis and pool replenishment
In simple terms: When calcium enters the cell, DCVs fuse with the membrane and release their contents.
DCV fusion is triggered by calcium influx and can be quantitatively analyzed in rodent CNS neurons. Hippocampal neurons exhibit maximal fusion capacity and efficient replenishment of the DCV pool, allowing repeated rounds of release. This regulated exocytosis is essential for neuropeptide signaling.
Key Genes Involved in GO:0098992 neuronal dense core vesicle
The following genes and proteins are central to neuronal dense core vesicle biology, based on published studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CHGA | Chromogranin A, major DCV cargo protein | Affects DCV biogenesis and exocytosis |
| CHGB | Chromogranin B, major DCV cargo protein | Affects DCV biogenesis and exocytosis |
| SYN1 | Synapsin I, DCV capture and release | Required for cAMP-dependent neuropeptide release |
| KIF5A | Kinesin-1 heavy chain, DCV transport | Mediates microtubule-dependent DCV movement |
| KLC1 | Kinesin light chain, DCV transport | Component of kinesin-1 motor for DCV trafficking |
| STXBP5 | Tomosyn, regulates DCV composition | Affects DCV cargo without blocking exocytosis |
| PCSK1 | Prohormone convertase 1/3 | Processes prohormones into active neuropeptides |
| PCSK2 | Prohormone convertase 2 | Processes prohormones into active neuropeptides |
| SCG2 | Secretogranin II | DCV cargo and sorting |
| SCG3 | Secretogranin III | DCV cargo and sorting |
| VAMP2 | Vesicle-associated membrane protein 2 | Mediates DCV fusion with plasma membrane |
| SNAP25 | Synaptosomal-associated protein 25 | Part of SNARE complex for DCV exocytosis |
| STX1A | Syntaxin 1A | Part of SNARE complex for DCV exocytosis |
| RAB3A | Small GTPase involved in vesicle trafficking | Regulates DCV docking and fusion |
| RAB27A | Small GTPase for DCV transport | Mediates DCV movement and release |
| CADPS | Calcium-dependent activator protein for secretion | Promotes DCV exocytosis |
| NSF | N-ethylmaleimide-sensitive factor | Recycles SNARE complexes after DCV fusion |
How Is neuronal dense core vesicle Regulated?
Neuronal dense core vesicle release is regulated by cAMP signaling and cytoskeletal capture mechanisms. Synapsin is required for DCV capture and cAMP-dependent neuropeptide release, linking second-messenger pathways to vesicle availability. Tomosyn influences DCV composition but does not block exocytosis, suggesting that cargo sorting is regulated independently of fusion. Kinesin-1-dependent transport also modulates DCV distribution and organismal physiology, including lifespan regulation in C. elegans. Additionally, the presynaptic cytomatrix provides structural organization that regulates DCV docking and fusion.
neuronal dense core vesicle and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CHGA | Alzheimer's disease, neuroendocrine tumors | CHGA knockout or overexpression in neuronal cultures |
| CHGB | Alzheimer's disease, neuroendocrine tumors | CHGB knockout or overexpression in neuronal cultures |
| KIF5A | Neurodegeneration, hereditary spastic paraplegia | KIF5A knockout or point mutation in neurons |
| SYN1 | Epilepsy, neurodevelopmental disorders | SYN1 knockout in hippocampal neurons |
| STXBP5 | Neuropsychiatric disorders | STXBP5 knockout or knockdown in neurons |
Alzheimer's disease
Dense core vesicle markers are altered in cerebrospinal fluid and cortical tissues of patients with Alzheimer's disease, suggesting that DCV dysfunction may contribute to disease pathology. Chromogranins, major DCV cargo proteins, have been implicated in neurodegenerative processes.
Neurodevelopmental and neuropsychiatric disorders
Because DCVs release neuropeptides that modulate behavior, defects in DCV biogenesis, transport or release may underlie neurodevelopmental and neuropsychiatric conditions. Kinesin-1 mutations affecting DCV transport are associated with altered locomotion and lifespan in model organisms.
Neuroendocrine disorders
DCV cargo proteins such as chromogranins and prohormone convertases are critical for neuroendocrine signaling; their dysfunction can lead to impaired processing of prohormones and altered neuropeptide release.
From neuronal dense core vesicle-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a gene affect DCV biogenesis? | Knockout of candidate gene in neuronal cultures |
| Does a mutation alter DCV transport? | Point mutation knock-in in C. elegans or mouse neurons |
| Does a gene product localize to DCVs? | Tagged knock-in with fluorescent protein |
| Does overexpression change DCV release? | Overexpression of candidate gene in hippocampal neurons |
| Does a gene regulate DCV capture? | Knockout of synapsin in primary neurons |
| Does a gene affect DCV composition? | Proteomics of DCVs from knockout neurons |
How to Study the neuronal dense core vesicle Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | DCV fusion events and pool replenishment | Quantifying release capacity in hippocampal neurons |
| Proteomics | DCV cargo composition | Identifying changes in knockout or mutant neurons |
| Fluorescence tracking | DCV transport velocity and direction | Assessing kinesin-1 function in neurons |
| Electrophysiology | Neuropeptide release and cAMP dependence | Studying synapsin function in DCV capture |
| Immunofluorescence | DCV localization in neuronal compartments | Mapping DCV distribution in soma, dendrites and axons |
| CSF biomarker analysis | DCV marker levels in patient samples | Alzheimer's disease biomarker studies |
| Genetic knockout | Gene function in DCV biogenesis | Chromogranin knockout models |
| Quantitative fusion assay | Maximal fusion capacity | Comparing wild-type and mutant neurons |
Quantitative DCV fusion analysis
Quantitative analysis of dense-core vesicle fusion in rodent CNS neurons allows measurement of fusion capacity and pool replenishment. This method uses fluorescent cargo markers and time-lapse imaging to track individual fusion events.
Proteomic profiling of DCV cargo
Proteomic analysis of isolated DCVs can reveal changes in cargo composition, as demonstrated for tomosyn mutants. This approach identifies proteins that co-purify with DCVs and helps define the molecular signature of these organelles.
Live-cell imaging of DCV transport
Live-cell imaging of fluorescently tagged DCVs enables tracking of their movement along axons and dendrites. Kinesin-1-dependent transport can be assessed by analyzing velocity, directionality and distribution of DCVs.
Electrophysiology and cAMP signaling assays
Electrophysiological recordings combined with cAMP modulators can measure DCV exocytosis and its dependence on second messengers. Synapsin knockout neurons show impaired cAMP-dependent neuropeptide release, demonstrating the utility of this approach.
How CRISPR Can Be Used to Study GO:0098992 neuronal dense core vesicle
Knockout
CRISPR knockout of genes such as CHGA, CHGB or SYN1 can reveal their roles in DCV biogenesis, capture and release. Knockout neuronal cultures can be analyzed by imaging and proteomics to assess DCV number, composition and fusion capacity.
Point Mutation
Point mutations in genes like KIF5A can be introduced to model transport defects observed in neurodegenerative diseases. These mutations allow precise testing of how specific amino acid changes affect DCV trafficking and organismal phenotypes.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous DCV cargo genes enables real-time tracking of DCVs in live neurons. Tagged knock-in models preserve endogenous regulation and are ideal for imaging studies.
Overexpression
Overexpression of DCV cargo proteins or regulators can be achieved via CRISPR activation or lentiviral delivery to study gain-of-function effects on DCV release. Overexpression of synapsin or chromogranins may enhance or disrupt DCV function.
How EDITGENE Supports neuronal dense core vesicle Research
Researchers studying neuronal dense core vesicle-related genes often need to determine whether a candidate gene is causally involved in DCV biogenesis, transport, capture or release. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional studies of DCV biology.
Contact EDITGENE today to design your custom CRISPR model for neuronal dense core vesicle research.
Frequently Asked Questions About neuronal dense core vesicle
What is GO:0098992 neuronal dense core vesicle?
GO:0098992 is a Gene Ontology term for a dense core vesicle located in neurons that typically contains neuropeptides and can be found in the soma, dendrites, axonal varicosities and synaptic terminals.
What genes are involved in neuronal dense core vesicles?
Key genes include CHGA, CHGB, SYN1, KIF5A, STXBP5, PCSK1, PCSK2, SCG2, SCG3, VAMP2, SNAP25, STX1A, RAB3A, RAB27A, CADPS and NSF.
How are dense core vesicles different from synaptic vesicles?
Dense core vesicles are larger, contain an electron-dense core, store neuropeptides, and can release cargo from multiple neuronal compartments, whereas synaptic vesicles are smaller and primarily release classical neurotransmitters.
What is the function of dense core vesicles in neurons?
They store and release neuropeptides and other signaling molecules in a regulated manner, modulating neuronal activity and behavior.
How are dense core vesicles transported in neurons?
They are transported along microtubules by motor proteins, particularly kinesin-1, which moves them to release sites throughout the neuron.
What diseases are associated with dense core vesicle dysfunction?
Alzheimer's disease and other neurodegenerative conditions show altered DCV markers, and defects in DCV transport are linked to neurodegeneration.
How can I study dense core vesicle release?
Quantitative fusion assays in rodent CNS neurons and live-cell imaging of fluorescently tagged DCVs are commonly used.
What is the role of synapsin in dense core vesicles?
Synapsin is required for DCV capture and cAMP-dependent neuropeptide release.
What is the role of chromogranins in dense core vesicles?
Chromogranins A and B are major cargo proteins that affect DCV biogenesis and exocytosis.
Can CRISPR be used to study dense core vesicles?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models can be used to dissect gene function in DCV biology.
Conclusion
Neuronal dense core vesicles (GO:0098992) are essential organelles for neuropeptide storage and regulated release in neurons. Their biogenesis, transport, capture and fusion are controlled by a complex machinery involving chromogranins, synapsin, kinesin-1 and SNARE proteins. Dysregulation of DCV biology is linked to Alzheimer's disease and other neurological conditions. Advances in quantitative imaging and CRISPR-based models continue to illuminate DCV function, offering new opportunities for therapeutic intervention. EDITGENE provides end-to-end CRISPR services to accelerate research on neuronal dense core vesicles, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Subkhangulova A et al.. 2023. Tomosyn affects dense core vesicle composition but not exocytosis in mammalian neurons.. Elife 12 PMID: 37695731
- 2. Moro A et al.. 2021. Quantitative analysis of dense-core vesicle fusion in rodent CNS neurons.. STAR Protoc 2(1):100325 PMID: 33659902
- 3. Jin Y et al.. 2023. Presynaptic Cytomatrix Proteins.. Adv Neurobiol 33:23-42 PMID: 37615862
- 4. Barranco N et al.. 2021. Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer's disease.. Transl Neurodegener 10(1):37 PMID: 34565482
- 5. Yu SC et al.. 2021. Synapsin Is Required for Dense Core Vesicle Capture and cAMP-Dependent Neuropeptide Release.. J Neurosci 41(19):4187-4201 PMID: 33820857
- 6. Dominguez N et al.. 2018. Dense-core vesicle biogenesis and exocytosis in neurons lacking chromogranins A and B.. J Neurochem 144(3):241-254 PMID: 29178418
- 7. Gavrilova A et al.. 2024. The role of kinesin-1 in neuronal dense core vesicle transport, locomotion and lifespan regulation in C. elegans.. J Cell Sci 137(17) PMID: 39171448
- 8. Baginska U et al.. 2023. Maximal Fusion Capacity and Efficient Replenishment of the Dense Core Vesicle Pool in Hippocampal Neurons.. J Neurosci 43(45):7616-7625 PMID: 37852790
